MACSF

COMMUNIQUÉS West-GlobeNewswire

Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results, Provide Corporate Update and Host Conference Call
08/02/2024
MENLO PARK, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report fourth quarter and full-year 2023 financial results and provide a corporate update on [...]
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 29, 2024
08/02/2024
CANTON, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions [...]
Amneal Announces Complete Response Resubmission for IPX203 New Drug Application
08/02/2024
BRIDGEWATER, N.J., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) (“Amneal” or the “Company”) today announced that it has provided a Complete Response resubmission to the U.S. Food and [...]
Corvus Pharmaceuticals Announces Orphan Drug Designation Granted to Soquelitinib for the Treatment of T Cell Lymphoma
08/02/2024
Company on track to initiate soquelitinib Phase 3 registrational clinical trial in PTCL BURLINGAME, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage [...]
Athira Pharma Announces Publication in Frontiers in Neuroscience Highlighting Therapeutic Potential of ATH-1105 in Amyotrophic Lateral Sclerosis (ALS)
08/02/2024
Results demonstrate ATH-1105 is neuroprotective, preserves motor and nerve function and extends survival in preclinical models of ALS BOTHELL, Wash., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA [...]
BioXcel Therapeutics Announces Proposed Public Offering
08/02/2024
NEW HAVEN, Conn., Feb. 08, 2024 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (the “Company”) (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines [...]
Celyad Oncology announces intention to terminate SEC reporting obligations
08/02/2024
MONT-SAINT-GUIBERT, Belgium, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) announces that it will voluntarily file a Form 15F with the United States [...]
Rhythm Pharmaceuticals Announces New Employment Inducement Grants
08/02/2024
BOSTON, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the lives of patients and their families living with rare [...]
PetMeds® Announces Selected Preliminary Third Quarter Financial Results
08/02/2024
Company to Restate Certain Previously Issued Financial Statements Due to Correction of Errors in Accounting for Tax-Related Entries; Filing of Form 10-Q to be Delayed DELRAY BEACH, Fla., Feb. 08, 2024 (GLOBE NEWSWIRE [...]
Ultragenyx to Host Conference Call for Fourth Quarter and Full-Year 2023 Financial Results and Corporate Update
08/02/2024
NOVATO, Calif., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for serious rare and [...]
NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13
08/02/2024
EDEN PRAIRIE, Minn., Feb. 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and [...]
Federal government needs to clear up confusion about Canadian Dental Care Plan
08/02/2024
The CDCP isn’t free from cost and red tape MEDIA RELEASE: Canada's Provincial and Territorial Dental Associations TORONTO, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Dentists know that the Canadian Dental Care Plan (CDCP) is a [...]
Correction Notice of Palisade Bio’s Press Release Announcing the Appointment of Clinical Advisory Board Members
08/02/2024
Carlsbad, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a biopharmaceutical company focused on developing novel therapeutics for serious chronic gastrointestinal [...]
The Novozymes Report 2023
08/02/2024
This annual report has been released subsequent to the approval of the combination of Novozymes and Chr. Hansen on January 29, 2024. The new combined group is called Novonesis. As an annual report is required to cover [...]
The Association of American Physicians and Surgeons (AAPS) Files Amicus Brief Against Biden Administration’s Censorship
08/02/2024
TUCSON, Ariz., Feb. 08, 2024 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons (AAPS) has filed an amicus curiae brief in the U.S. Supreme Court in opposition to the censorship imposed by the Biden [...]
CARBIOS annonce la mise en œuvre d'un programme d'actionnariat salarié
08/02/2024
Clermont-Ferrand, France, le 8 février 2024 (18:30 CET). CARBIOS (la « Société », Euronext Growth Paris : ALCRB) annonce ce jour le lancement d'un plan d’actionnariat salarié 2024, au bénéfice de l’ensemble de ses [...]
U.S. Organ Procurement Organizations are Strong, CMS Rule Threatens Future Success of Donation System
08/02/2024
47 out of 56 OPOs broke records recovering organs for transplant in 2023, yet nearly half could be decertified in 2026 MCLEAN, Va., Feb. 08, 2024 (GLOBE NEWSWIRE) -- The Association of Organ Procurement Organizations ( [...]
Accumulus Synergy lance sa plateforme basée sur le cloud très attendue
08/02/2024
Les autorités de réglementation dans le monde entier s’impliquent alors que l’organisation à but non lucratif soutient un projet international axé sur la confiance réglementaire BURLINGAME, Californie, 08 févr. 2024 ( [...]
Cell BioEngines to Present at the 2024 BIO CEO & Investor Conference
08/02/2024
Clinical-Stage Biotech to Unveil Off-the-Shelf Non-Gene Modified Hematopoietic Stem Cells and Its Derived Immune Cell Therapies NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Cell BioEngines, Inc., a biotechnology company [...]

Pages